RECURRENT GLIOBLASTOMA
Clinical trials for RECURRENT GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for RECURRENT GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Laser zaps brain tumor, then immunotherapy fights back: new hope for glioblastoma?
Disease control Not yet recruitingThis study tests a new approach for recurrent glioblastoma, an aggressive brain cancer. It combines a minimally invasive laser that heats and destroys tumor tissue (LiTT) with an immunotherapy drug called cemiplimab, which helps the immune system attack cancer cells. About 99 par…
Matched conditions: RECURRENT GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Supercharged immune cells take on deadly brain tumors
Disease control Not yet recruitingThis early-stage trial tests a new approach for people with recurrent glioblastoma, an aggressive brain cancer that has come back after standard treatment. Researchers will give patients specially engineered natural killer (NK) cells, either directly into the brain or through an …
Matched conditions: RECURRENT GLIOBLASTOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New brain cancer drug BRiTE enters first human safety trial
Disease control Not yet recruitingThis early-stage study tests a new drug called BRiTE for safety in 18 adults with a specific type of glioblastoma (a fast-growing brain cancer). The drug is given as a continuous IV drip over 4 days each month. Only patients whose tumors have a specific genetic marker (EGFRvIII) …
Matched conditions: RECURRENT GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC